Want to track 2M6 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
2M6 earnings report is expected in 85 days (20 May 2026)
Summary
2M6 closed today lower at €81.81, a decrease of 1.79% from yesterday's close, completing a monthly decrease of -0.16% or €0.13. Over the past 12 months, 2M6 stock lost -0.16%.
2M6 pays dividends to its shareholders, with the most recent payment made on Jan 16, 2026. The next estimated payment will be in In 1 month on Apr 16, 2026 for a total of €0.71.
The last earnings report, released on Feb 17, 2026, missed the consensus estimates by -1.33%. On average, the company has fell short of earnings expectations by -1.29%, based on the last three reports. The next scheduled earnings report is due on May 20, 2026.
Medtronic plc has completed 7 stock splits, with the recent split occurring on Sep 27, 1999.
The company's stock is traded on 12 different exchanges and in various currencies, with the primary listing on NYSE (USD).
2M6 Chart
1 Reason I'd Buy Medtronic Stock and Never Sell
Medtronic is one of the world's largest medical device companies. Its dividend streak speaks volumes about the strength of its business.
Fool | 1 day ago
Medtronic's “Textbook” Reversal: How High Can It Really Go in 2026?
Medtronic's NYSE: MDT stock price is amid a textbook reversal, having formed a Head & Shoulders Pattern and broken to fresh highs, confirming the baseline as a critical pivot point. The question now is how high the stock might rise.
Marketbeat | 6 days ago
Medtronic plc (MDT) Q3 2026 Earnings Call Transcript
Medtronic plc (MDT) Q3 2026 Earnings Call Transcript
Seekingalpha | 6 days ago
Medtronic plc (2M6) FAQ
What is the stock price today?
The current price is €81.81.
On which exchange is it traded?
Medtronic plc is listed on NYSE.
What is its stock symbol?
The ticker symbol is 2M6.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 2.76%.
What is its market cap?
As of today, no market cap data is available.
What is the earnings per share?
The EPS is 1.67.
When is the next earnings date?
The next earnings report will release on May 20, 2026.
Has Medtronic plc ever had a stock split?
Medtronic plc had 7 splits and the recent split was on Sep 27, 1999.
Medtronic plc Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Geoffrey Straub Martha CEO | XMUN Exchange | IE00BTN1Y115 ISIN |
| IE Country | 95,000 Employees | 26 Dec 2025 Last Dividend | 27 Sep 1999 Last Split | 13 Jan 1978 IPO Date |
Overview
Medtronic plc is a global leader in medical technology, specializing in the development, manufacture, and sale of device-based medical therapies. Serving healthcare systems, physicians, clinicians, and patients around the world, the company is dedicated to alleviating pain, restoring health, and extending life for millions of people. Founded in 1949 and headquartered in Dublin, Ireland, Medtronic operates across various medical domains through its diverse portfolio which includes cardiovascular, medical surgical, neuroscience, and diabetes treatments and technologies.
Products and Services
Medtronic’s comprehensive range of products and services is categorized into four primary segments:
- Cardiovascular Portfolio: This segment offers advanced device-based solutions for cardiac care, including:
- Implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices for heart rhythm management.
- Cardiac ablation products for treating atrial fibrillation.
- Insertable cardiac monitor systems for continuous heart monitoring.
- TYRX products, which involve antimicrobial envelopes for electronic implantable devices.
- Aortic valves, surgical valve replacement and repair products, transcatheter pulmonary valves, and endovascular stent grafts for structural heart disease treatment.
- Percutaneous coronary intervention products and angioplasty balloons for coronary artery disease treatment.
- Remote monitoring and patient-centered software for enhanced patient care.
- Medical Surgical Portfolio: This segment encompasses a broad array of surgical instruments and devices, including:
- Surgical stapling devices and vessel sealing instruments for precise surgical procedures.
- Wound closure products and electrosurgery products aimed at efficient surgical recovery.
- Surgical artificial intelligence and robotic-assisted surgery products for advanced surgical techniques.
- Hernia mechanical devices and mesh implants, along with other gynecology and lung health products.
- Minimally invasive gastrointestinal and hepatologic diagnostic and therapy tools, patient monitoring, airway management and ventilation therapies, and renal disease treatments.
- Neuroscience Portfolio: This segment delivers solutions for the central nervous system and supportive structures, including:
- Products for spinal, neuro, and orthopedic surgeries, pain management, and urology.
- Energy surgery instruments and image-guided surgery systems for enhanced surgical accuracy.
- Intra-operative imaging and robotic guidance systems for spine procedures.
- Therapies for brain vasculature conditions.
- Diabetes Operating Unit: Focused on diabetes management, this segment offers:
- Insulin pumps and consumables for continuous insulin delivery.
- Continuous glucose monitoring systems for real-time blood glucose tracking.
- Smart insulin pen systems and related consumables for modern diabetes care.
Contact Information
Address: 20 On Hatch
Phone: 353 1 438 1700
Website: https://www.medtronic.com
